- Home
- Companies
- Obsidian Therapeutics, Inc.
- Products
- Model cytoTIL15 - Cell and Gene Therapy
Model cytoTIL15 - Cell and Gene Therapy
Engineered with membrane-bound IL15, Eliminates toxic IL2 regimen, increasing patient accessibility to TIL therapy, Drives improved persistence, IL15 expression controlled by acetazolamide (ACZ), via cytoDRiVE® technology.
-
Most popular related searches
Customer reviews
No reviews were found for Model cytoTIL15 - Cell and Gene Therapy. Be the first to review!